Address
Email address
Website
New standard in soft tissue assessment - myotonometer MyotonPRO Digital Palpation Device is non-invasive, reliable, quick and easy to use research tool.
Name
Myoton AS
Registry code
10533818
VAT number
EE100516818
Type
AS - Joint Stock Company
Status
Registered
Foundation date
22.03.1999 (25)
Financial year
01.01-31.12
Capital
120 000.00 €
Activity
26601 - Manufacture of irradiation, electromedical and electrotherapeutic equipment
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Broadleaf Invest OÜ 11007376 | 80% - 96 000.00 EUR | - | - | Shareholder |
Aleko Peipsi 03.11.1966 (57) | 20% - 24 000.00 EUR | Board member | Direct ownership | Shareholder |
Lehtmets Jaanus 12.05.1973 (51) | - | Board member | Direct ownership | |
Merle Peipsi 17.12.1966 (57) | - | - | - | Board member |
Taisi Lehtmets 20.07.1974 (50) | - | - | - | Board member |
Märt Kosemets 25.01.1981 (43) | - | - | - | Chairman of the board |
Arved Vain 29.10.1936 (87) | - | - | - | Founder |
2019 15.04.2020 | 2020 12.04.2021 | 2021 07.03.2022 | 2022 28.03.2023 | |
---|---|---|---|---|
Total Revenue | 464 534 € | 346 403 € | 476 606 € | 582 117 € |
Net profit (loss) for the period | 139 947 € | 26 391 € | 41 854 € | 221 927 € |
Profit Margin | 30% | 8% | 9% | 38% |
Current Assets | 167 500 € | 137 900 € | 150 955 € | 254 159 € |
Fixed Assets | 837 087 € | 876 510 € | 901 230 € | 997 260 € |
Total Assets | 1 004 587 € | 1 014 410 € | 1 052 185 € | 1 251 419 € |
Current Liabilities | 58 102 € | 99 534 € | 100 455 € | 87 762 € |
Non Current Liabilities | 442 932 € | 406 932 € | 401 932 € | 391 932 € |
Total Liabilities | 501 034 € | 506 466 € | 502 387 € | 479 694 € |
Share Capital | 120 000 € | 120 000 € | 120 000 € | 120 000 € |
Equity | 503 553 € | 507 944 € | 549 798 € | 771 725 € |
Employees | 1 | 1 | 2 | 2 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 148 129.19 € | 21 086 € | 19 690.04 € | 2 |
2023 Q4 | 174 497.08 € | 20 144.11 € | 20 887.45 € | 2 |
2023 Q3 | 148 504.97 € | 20 062.09 € | 20 875.95 € | 2 |
2023 Q2 | 121 466.66 € | 15 702.83 € | 16 265.21 € | 2 |
2023 Q1 | 240 763.9 € | 21 992.98 € | 22 172.26 € | 2 |
2022 Q4 | 146 139.29 € | 15 901.91 € | 16 451.26 € | 2 |
2022 Q3 | 107 913.84 € | 14 062.27 € | 14 523.05 € | 2 |
2022 Q2 | 130 270 € | 12 588.4 € | 12 906.94 € | 2 |
2022 Q1 | 214 005.77 € | 16 870.93 € | 17 432.44 € | 2 |
2021 Q4 | 20 290 € | 13 352.77 € | 13 779.11 € | 2 |
2021 Q3 | 141 960.88 € | 15 199.02 € | 15 649.23 € | 1 |
2021 Q2 | 100 940.6 € | 17 029.03 € | 13 446.03 € | 2 |
2021 Q1 | 148 705 € | 14 038.34 € | 14 458.41 € | 2 |
2020 Q4 | 138 099.13 € | 9 278.32 € | 11 197.02 € | 2 |
2020 Q3 | 63 026.08 € | 11 403.36 € | 11 288.62 € | 2 |
2020 Q2 | 53 102.44 € | 9 992.14 € | 11 242.83 € | 2 |
2020 Q1 | 103 843 € | 11 896.95 € | 12 170.46 € | 2 |